2014
DOI: 10.1186/1471-2334-14-s7-p25
|View full text |Cite
|
Sign up to set email alerts
|

Differential diagnosis of reactive arthritis in a patient with intravesical BCG immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In particular, BCG efficacy is limited by its potential adverse reaction profile showing a cause of side-effects for approximately 90% of patients affected with bladder cancer [12], [29]. Recently, Roxana Aguridǎ et al [3] reported many kind of BCG side-effects including arthritis for a 50 years-old female patient affected with bladder cancer, operated in January 2014. On the other hand, research on urology reported in several papers that the optimal dose of BCG, its maintenance schedule and duration of its treatment, are yet unknown [1].…”
Section: Overview On Bacillus Calmette-guérin (Bcg)mentioning
confidence: 99%
“…In particular, BCG efficacy is limited by its potential adverse reaction profile showing a cause of side-effects for approximately 90% of patients affected with bladder cancer [12], [29]. Recently, Roxana Aguridǎ et al [3] reported many kind of BCG side-effects including arthritis for a 50 years-old female patient affected with bladder cancer, operated in January 2014. On the other hand, research on urology reported in several papers that the optimal dose of BCG, its maintenance schedule and duration of its treatment, are yet unknown [1].…”
Section: Overview On Bacillus Calmette-guérin (Bcg)mentioning
confidence: 99%